Remove Arrhythmia Remove Atrial Fibrillation Remove Cardiomyopathy
article thumbnail

Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy

Frontiers in Cardiovascular Medicine

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

article thumbnail

PO-05-111 CLINICAL OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND ATRIAL TACHYCARDIA IN WILD-TYPE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A PROPOSED TREATMENT STRATEGY FOR CATHETER ABLATION IN EACH ARRHYTHMIA

HeartRhythm

Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is often accompanied by atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia (AT), which are difficult to control because beta-blockers and antiarrhythmic drugs can worsen heart failure (HF).

article thumbnail

Efficacy and Clinical Outcomes of Catheter Ablation for Atrial Arrhythmia in Cardiac Amyloidosis

HeartRhythm

Cardiac amyloidosis (CA) involves the abnormal accumulation of misfolded proteins in the heart muscle, leading to restrictive cardiomyopathy.1 Atrial arrhythmias (AA), particularly atrial fibrillation (AF), are prevalent in CA and may impact long-term cardiovascular outcomes, prompting an investigation into early rhythm management strategies.2

article thumbnail

PO-02-054 EARLY DETECTION OF ATRIAL FUNCTIONAL MITRAL REGURGITATION IN ATRIAL FIBRILLATION PATIENTS USING ECG AND DEEP LEARNING

HeartRhythm

Atrial fibrillation (AF), a common cardiac arrhythmia, often results in significant atrial remodeling, including atrial cardiomyopathy and dilatation. Notably, aFMR is linked to a higher recurrence rate of AF after catheter ablation.

article thumbnail

Case Report: Multiple types of arrhythmias in a late-confirmed Danon disease

Frontiers in Cardiovascular Medicine

Introduction Danon disease is an X-linked disorder caused by pathogenic variants in lysosome-associated membrane protein 2 ( LAMP2 ) gene, typically characterized by the triad of hypertrophic cardiomyopathy, myopathy, and intellectual disability. However, many patients may not present the typical presentation, especially in the early stage.

article thumbnail

Anticoagulation in Post-Operative AFib, Non-ST-Elevation Acute Coronary Syndromes, Arrhythmia-Induced Cardiomyopathy

American College of Cardiology

In this week’s View, Dr. Eagle looks at anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting. He then examines a meta-analysis of invasive vs. conservative management of non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting.

article thumbnail

Prognostic Value of Low Voltage Area Burden in Atrial Fibrillation

HeartRhythm

The EHRA/HRS/APHRS/SOLAECE Expert Consensus on Atrial Cardiomyopathies published in 2017 defined atrial cardiomyopathy as “any complex of structural, architectural, contractile, or electrophysiological changes affecting the atria.”1